New Collagen Product Launches at 1,999 Yuan as China's Biomedical Beauty Market Expands

Gate News message, April 23 — Xinyang (SY.US) and Jinbo Biotech (920982.BJ) announced a strategic partnership on April 22, with Jinbo's new collagen product Weiyi Beauty ColPact being exclusively supplied to Xinyang Youth Clinic. Xinyang launched "Miracle Collagen" based on this product for facial and scalp anti-aging, priced at 1,999 yuan per unit or 2,999 yuan for two units.

China's collagen market is rapidly expanding, with 18 Class III medical device registration certificates now approved as of April 2026. According to industry data, the market for recombinant collagen products has grown significantly, with market penetration reaching 56.9% in 2025. The Chinese medical aesthetics collagen injection market reached approximately 6.7 billion yuan in 2024, with a compound annual growth rate of 21.9% from 2021 to 2024. Recombinant collagen products alone are projected to reach 58.6 billion yuan by 2025, with forecasts suggesting the market will exceed 100 billion yuan by 2027.

Jinbo Biotech's chairman Yang Xia noted that the company's collagen products were initially priced around 6,900 yuan due to production capacity constraints of only 300 liters. The company has since expanded capacity to 3 tons and plans further expansion to 5 tons. Yang stated that at 5-ton capacity, the price will approach production cost and will not decrease further, as companies must maintain profit margins for continued research and development. Regarding price competition concerns, Xinyang CEO Jin Xing stated that prices are ultimately determined by supply and demand dynamics, and as more products enter the market, a tiered pricing structure—high-end (over 10,000 yuan), mid-range (4,000-6,000 yuan), and budget (500-2,000 yuan)—will emerge to serve diverse consumer needs and expand market penetration.